Business Description
Nanobiotix is a Paris-based biotech company founded in 2003 that develops cancer treatments using a novel injectable particle technology called NBTXR3, which targets a wide range of tumor types including head and neck, liver, prostate, and lung cancers. The technology works by enhancing the effects of radiation therapy at the tumor site. Through a regional partnership with Lian Oncology, the company is also bringing this treatment to markets across Asia, including China, South Korea, Singapore, and Thailand.
